DIGIPLA

Plasmapheresis Machines

A Plasmapheresis Machine, designed for the separation and collection of plasma from whole blood utilized in therapeutic plasma exchange (TPE).

Output: 80% Plasma yield.

Features:

  • Single Needle & Intermittent Process
  • Total Plasma Collection: 3600mL
  • Touchscreen interface
  • Real-time display of treatment parameters
  • Data storage capabilities
  • Collections Per Cycle: 100-400g

Advantages:

  • Closed circuit: No chance of infections.
  • No need of licence.
Applications

PLASMAPHERESIS TREATMENT

OPHTHALMOLOGY

– Age-related Macular Degeneration (AMD)

– Malignant Exophthalmos

NEUROLOGY

– Myasthenia Gravis (MG)

– Multiple Sclerosis (MS)

– Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

– Guillain – Barre Syndrome (GBS)

– Lambert – Eaton Myasthenic Syndrome (LEMS)

– Miller Fisher Syndrome (MFS)

– Crow-Fukase Syndrome (CFS)

NEPHROLOGY

– Focal Segmental Glomerulosclerosis (FSGS)

– ANCA – Associated Glomerulonephritis

– Henoch – Schönlein Purpura Nephritis

– ABO Blood Group Incompatible or Acquired

– Lymphocyte Antibody Positive Kidney Transplant

ANGIOLOGY

– Peripheral Arterial Occlusive Disease

– Arteriosclerosis Obliterans (ASO)

GASTROENTEROLOGY

– Hepatic Encephalopathy

HEMOTOLOGY

– Thrombotic Thrombocytopenic Purpura (TTP)

– Multiple Myeloma (MM)

– Acquired Factor VIII Positive Hemophilia Severe ABO Blood Group Incompatible

– Pregnancy

– Cryoglobulinemia

– Macroglobulinemia

CARDIOLOGY

– Familial Hypercholesterolemia (FH)

RHEUMATOLOGY (COLLAGEN – VASCULAR DISEASE)

– Systemic Lupus Erythematosus (SLE)

– Malignant Rheumatoid Arthritis (MRA)

– Progressive Systemic Sclerosis (PSS)

– Syndrome (SJS) Dermatomyositis (DM)

– Polymyositis (PM)

– Wegner’s Granulomatosis (WG)

– Adult – Onset Still’s Disease (AOSD)

– Mixed Connective Tissue Disease (MCTD)

DERMATOLOGY

– Bullous Pemphigoid (BP)

– Toxic Epidermal Necrolysis (TEN)

– Pemphigus Vulgaris (PV)

EMERGENCY MEDICINE

– Paraquat Poisoning

– Snake Bite

Value Proposition

Unique form of partnerships offered to government medical schools and hospitals for our unique technology products through CSR donations, Placement models and free man – power support.

Zero capex, Zero Opex “on – call clinical services” model to private hospitals.

Technical manpower support, for every call, to administer treatments.

Improved outcomes with Digipla, a smaller number of procedures per treatment, zero cross contamination as with repeat use of plasma filters.

Achievements

Digipla has over 2000 procedures in the last 2 years.

NIMHANS, Apollo, Manipal, Gem Hospitals, and government medical schools use Digipla.

Continuously working with several government agencies to extent the best of treatment options to the citizens of the country.

Revolutionizing Healthcare through
Pioneering Technologies and Point-of-Care Excellence

We have continuously pushed the boundaries of innovation, introducing groundbreaking products and solutions to the Indian market.

Innovation

Duraent is a pioneering leader in static cold storage preservation, perfusion fluids, and machine perfusion technologies.

How we do

With an extensive distribution network and a dedicated team across India, Duraent covers all top hospitals, ensuring wide availability of products.

International Partnerships

Duraent actively partners with international innovators, marketing their products in India and actively contributing to the creation of brand equity.

Our Transformation

Transitioning from high-end marketing, Duraent is becoming a pioneering point-of-care services company, offering innovative solutions at the forefront of patient care.

How do we achieve it?

Innovation and excellence sets us apart, our success stories in media and various publications

Collaborative Partnerships

By forming strategic partnerships with global manufacturers, Duraent builds brand equity, expands market reach, and delivers high-quality healthcare products to customers.

Innovation and Research Excellence

Duraent drives its goals through relentless innovation and research excellence, continuously introducing groundbreaking products and solutions to meet evolving healthcare needs.

Customer-Centric Approach

Duraent prioritizes customer satisfaction by listening to their needs, tailoring products and services accordingly, and exceeding expectations through a customer-centric approach.

Our DIGIPLA Customers

Our customers are the pillars of our strength and motivation to strive for a better tomorrow.

Dr. Swaminathan

Utilized machine on more than 10 marginal organs (both liver and kidney). Vitasmart benefits lots of patients by transplanting them with Marginal organs which otherwise would have been discarded

Dr. Prabhu Kanchi

There are very less incidences of DGF, PNF and low rejection rates compared to static cold storage

Dr. Elankumaran K

Extended criteria organs were allocated to the patients benefited with shorter hospital stay

John M Kenedy

Far far away, behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts.

Arjun Pandit

Even the all-powerful Pointing has no control about the blind texts it is an almost unorthographic life One day however a small line of blind text by the name of Lorem Ipsum decided to leave for the far World of Grammar.

Global Partnerships

Latest Blogs

Our latest published articles

Interested to know more?

To learn more about Duraent's innovative organ preservation solutions and transplant technologies, contact us. Discover how we empower medical professionals to deliver life-saving results through groundbreaking products like VitaSmart™ and Belzer UW® Cold Storage Solution.

Request a Demo